{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:28:26Z","timestamp":1779164906141,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T00:00:00Z","timestamp":1571443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T00:00:00Z","timestamp":1571443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00296-019-04462-x","type":"journal-article","created":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T15:39:07Z","timestamp":1571499547000},"page":"465-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The coexistence of gout in ankylosing spondylitis patients: a case control study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1820-1890","authenticated-orcid":false,"given":"Tal","family":"Gonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-4297","authenticated-orcid":false,"given":"Shmuel","family":"Tiosano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Comaneshter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-7716","authenticated-orcid":false,"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8377-9982","authenticated-orcid":false,"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-8601","authenticated-orcid":false,"given":"Ora","family":"Shovman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,19]]},"reference":[{"key":"4462_CR1","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","volume":"374","author":"JD Taurog","year":"2016","unstructured":"Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374:2563\u20132574. \nhttps:\/\/doi.org\/10.1056\/NEJMra1406182","journal-title":"N Engl J Med"},{"key":"4462_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11882-014-0489-6","volume":"15","author":"JA Smith","year":"2014","unstructured":"Smith JA (2014) Update on ankylosing spondylitis: current concepts in pathogenesis. Curr Allergy Asthma Rep 15:489. \nhttps:\/\/doi.org\/10.1007\/s11882-014-0489-6","journal-title":"Curr Allergy Asthma Rep"},{"key":"4462_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61\u201366. \nhttps:\/\/doi.org\/10.1007\/s00296-002-0237-4","journal-title":"Rheumatol Int"},{"key":"4462_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379\u20131390. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"key":"4462_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649\u2013662. \nhttps:\/\/doi.org\/10.1038\/nrrheum.2015.91","journal-title":"Nat Rev Rheumatol"},{"key":"4462_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.rhu.0000111306.55417.19","volume":"10","author":"D Zlnay","year":"2004","unstructured":"Zlnay D, Rovensky J, Bosak V, Zlnay M (2004) The coincidence of ankylosing spondylitis and gouty arthritis. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 10:47\u201350. \nhttps:\/\/doi.org\/10.1097\/01.rhu.0000111306.55417.19","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"4462_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4274\/tftr.57.23","volume":"57","author":"N Yildiz","year":"2011","unstructured":"Yildiz N, Sutbeyaz ST, Koseoglu F (2011) Coexisting ankylosing spondylitis and gouty arthritis\/Ankilozan spondilit ve gut artriti birlikteligi. Turk J Phys Med Rehabil 57:111\u2013114. \nhttps:\/\/doi.org\/10.4274\/tftr.57.23","journal-title":"Turk J Phys Med Rehabil"},{"key":"4462_CR8","first-page":"773","volume":"21","author":"DM Wong","year":"1994","unstructured":"Wong DM, Chalmers IM (1994) Coexistent acute gouty arthritis and ankylosing spondylitis. A rare occurrence. J Rheumatol 21:773\u2013774","journal-title":"J Rheumatol"},{"key":"4462_CR9","first-page":"679","volume":"7","author":"J Duda","year":"2005","unstructured":"Duda J, Rovensky J, Tauchmannova H, Bakosova J (2005) Coincidence of ankylosing spondylitis, gouty arthritis and chondrocalcinosis articularis. Isr Med Assoc J IMAJ 7:679","journal-title":"Isr Med Assoc J IMAJ"},{"key":"4462_CR10","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s10067-007-0563-8","volume":"26","author":"H-H Ho","year":"2007","unstructured":"Ho H-H, Yu K-H, Chen J-Y, Lin J-L, Wu Y-JJ, Luo S-F, Liou L-B (2007) Coexisting ankylosing spondylitis and gouty arthritis. Clin Rheumatol 26:1655\u20131661. \nhttps:\/\/doi.org\/10.1007\/s10067-007-0563-8","journal-title":"Clin Rheumatol"},{"key":"4462_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10067-016-3477-5","volume":"36","author":"R Merdler-Rabinowicz","year":"2017","unstructured":"Merdler-Rabinowicz R, Tiosano S, Comaneshter D, Cohen AD, Amital H (2017) Comorbidity of gout and rheumatoid arthritis in a large population database. Clin Rheumatol 36:657\u2013660. \nhttps:\/\/doi.org\/10.1007\/s10067-016-3477-5","journal-title":"Clin Rheumatol"},{"key":"4462_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.autrev.2016.01.006","volume":"15","author":"E Houri Levi","year":"2016","unstructured":"Houri Levi E, Watad A, Whitby A, Tiosano S, Comaneshter D, Cohen AD, Amital H (2016) Coexistence of ischemic heart disease and rheumatoid arthritis patients\u2014a case control study. Autoimmun Rev 15:393\u2013396. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2016.01.006","journal-title":"Autoimmun Rev"},{"key":"4462_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12026-013-8395-x","volume":"56","author":"V Bieber","year":"2013","unstructured":"Bieber V, Cohen AD, Freud T, Agmon-Levin N, Gertel S, Amital H (2013) Autoimmune smoke and fire-coexisting rheumatoid arthritis and chronic obstructive pulmonary disease: a cross-sectional analysis. Immunol Res 56:261\u2013266. \nhttps:\/\/doi.org\/10.1007\/s12026-013-8395-x","journal-title":"Immunol Res"},{"key":"4462_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.autrev.2016.06.003","volume":"15","author":"S Dahan","year":"2016","unstructured":"Dahan S, Shor DB-A, Comaneshter D, Tekes-Manova D, Shovman O, Amital H, Cohen AD (2016) All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev 15:848\u2013853. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2016.06.003","journal-title":"Autoimmun Rev"},{"key":"4462_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/08916934.2015.1090985","volume":"49","author":"A Watad","year":"2016","unstructured":"Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H (2016) Hyperthyroidism association with SLE, lessons from real-life data\u2014a case\u2013control study. Autoimmunity 49:17\u201320. \nhttps:\/\/doi.org\/10.3109\/08916934.2015.1090985","journal-title":"Autoimmunity"},{"key":"4462_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/2Fj.rdc.2014.07.002","volume":"40","author":"LA MacFarlane","year":"2014","unstructured":"MacFarlane LA, Kim SC (2014) Gout: a review of non-modifiable and modifiable risk factors. Rheum Dis Clin N Am 40:581\u2013604. \nhttps:\/\/doi.org\/10.1016\/2Fj.rdc.2014.07.002","journal-title":"Rheum Dis Clin N Am"},{"key":"4462_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rdc.2014.01.008","volume":"40","author":"N Schlesinger","year":"2014","unstructured":"Schlesinger N (2014) Treatment of acute gout. Rheum Dis Clin N Am 40:329\u2013341. \nhttps:\/\/doi.org\/10.1016\/j.rdc.2014.01.008","journal-title":"Rheum Dis Clin N Am"},{"key":"4462_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/rheumatology\/keh043","volume":"43","author":"S Bajaj","year":"2004","unstructured":"Bajaj S, Fessler BJ, Alarcon GS (2004) Systemic lupus erythematosus and gouty arthritis: an uncommon association. Rheumatology 43:349\u2013352. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/keh043","journal-title":"Rheumatology"},{"key":"4462_CR19","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/annrheumdis-2014-205212","volume":"74","author":"JF Merola","year":"2015","unstructured":"Merola JF, Wu S, Han J, Choi HK, Qureshi AA (2015) Psoriasis, psoriatic arthritis, and risk of gout in US men and women. Ann Rheum Dis 74:1495\u20131500. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-205212","journal-title":"Ann Rheum Dis"},{"key":"4462_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206410","author":"C-F Kuo","year":"2016","unstructured":"Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M (2016) Comorbidities in patients with gout prior to and following diagnosis: case\u2013control study. Ann Rheum Dis [Internet]. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-206410","journal-title":"Ann Rheum Dis [Internet]"},{"key":"4462_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/RHU.0000000000000217","volume":"21","author":"RG Howard","year":"2015","unstructured":"Howard RG, Samuels J, Gyftopoulos S, Krasnokutsky S, Leung J, Swearingen CJ, Pillinger MH (2015) Presence of gout is associated with increased prevalence and severity of knee osteoarthritis: among older men: results of a pilot study. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 21:63\u201371. \nhttps:\/\/doi.org\/10.1097\/RHU.0000000000000217","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"4462_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jbspin.2012.03.013","volume":"79","author":"E Roddy","year":"2012","unstructured":"Roddy E, Doherty M (2012) Gout and osteoarthritis: a pathogenetic link? Jt Bone Spine 79:425\u2013427. \nhttps:\/\/doi.org\/10.1016\/j.jbspin.2012.03.013","journal-title":"Jt Bone Spine"},{"key":"4462_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"AG MacDonald","year":"2013","unstructured":"MacDonald AG, Downham C, Jones GT, Macfarlane GJ, Dean LE, Sturrock RD (2013) Global prevalence of ankylosing spondylitis. Rheumatology 53:650\u2013657. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ket387","journal-title":"Rheumatology"},{"key":"4462_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10067-006-0380-5","volume":"26","author":"D Malesci","year":"2006","unstructured":"Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G (2006) High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 26:710. \nhttps:\/\/doi.org\/10.1007\/s10067-006-0380-5","journal-title":"Clin Rheumatol"},{"key":"4462_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/BOR.0b013e3282f4b1ed","volume":"20","author":"JG Puig","year":"2008","unstructured":"Puig JG, Mart\u00ednez MA (2008) Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 20:187. \nhttps:\/\/doi.org\/10.1097\/BOR.0b013e3282f4b1ed","journal-title":"Curr Opin Rheumatol"},{"key":"4462_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/archinte.165.7.742","volume":"165","author":"HK Choi","year":"2005","unstructured":"Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165:742\u2013748. \nhttps:\/\/doi.org\/10.1001\/archinte.165.7.742","journal-title":"Arch Intern Med"},{"issue":"10","key":"4462_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","volume":"19","author":"GE Thottam","year":"2017","unstructured":"Thottam GE, Krasnokutsky S, Pillinger MH (2017) Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep 19(10):60. \nhttps:\/\/doi.org\/10.1007\/s11926-017-0688-y","journal-title":"Curr Rheumatol Rep"},{"key":"4462_CR28","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1007\/s10067-016-3362-2","volume":"35","author":"N Ahmed","year":"2016","unstructured":"Ahmed N, Prior JA, Chen Y, Hayward R, Mallen CD, Hider SL (2016) Prevalence\u00a0of cardiovascular-related comorbidity in\u00a0ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. Clin Rheumatol 35:3069\u20133073. \nhttps:\/\/doi.org\/10.1007\/s10067-016-3362-2","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4462_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2018.22.1.1","volume":"22","author":"YS Yi","year":"2018","unstructured":"Yi YS (2018) Role of inflammasomes in inflammatory autoimmune rheumatic diseases. Korean J Physiol Pharmacol 22(1):1\u201315. \nhttps:\/\/doi.org\/10.4196\/kjpp.2018.22.1.1","journal-title":"Korean J Physiol Pharmacol"},{"key":"4462_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241. \nhttps:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04462-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T23:35:35Z","timestamp":1602977735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04462-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,19]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4462"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04462-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,19]]},"assertion":[{"value":"4 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Relationships relevant to this manuscript within the last 3\u00a0years: Prof. Arnon Cohen received research grants from Janssen, Novartis, AbbVie, Janssen, and Sanofi. Prof. Arnon Cohen served as a consultant, advisor, or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Samsung Bioepis, Sanofi, Sirbal, and Taro. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study fulfilled the ethical guidelines of the most recent Declaration of Helsinki and received approval by the local ethical committee of the Clalit Health Services on 27\/08\/18. The protocol number for this study was 0212-17-COM.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}